Relation between hippocampal γ waves and behavioral disturbances induced by phencyclidine and methamphetamine

Behavioural Brain Research

Volumn 111, Issue 1-2, 2000, Pages 1-11

  Ma, Jingyi ^a   Stan Leung, Lai Wo ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Gamma waves; Hippocampus; Medial septum; Methamphetamine; Phencyclidine; Psychomotor behavior; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; METHAMPHETAMINE; MUSCIMOL; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR DISORDER; C WAVE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; HIPPOCAMPUS; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTUM NUCLEUS; THETA RHYTHM; WALKING;

ANIMALS; AROUSAL; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; HALLUCINOGENS; HIPPOCAMPUS; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; PHENCYCLIDINE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, LONG-EVANS; SCHIZOPHRENIA; SEPTUM OF BRAIN;

EID: 0034659636     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(00)00138-8     Document Type: Article

References (67)

1. Allen R.M., Young S.J. Phencyclidine-induced psychosis. Am. J. Psychiatry. 135:1978;1081-1085.
2. Angrist B., Lee H.K., Gershon S. The antagonism of amphetamine-induced symptomatology by a neuroleptic. Am. J. Psychiatry. 131:1974;817-819.
3. Angrist B., Gershon S. The phenomenology of experimentally induced amphetamine psychosis - preliminary observations. Biol. Psychiatry. 2:1970;95-107.
4. Akpinar S., Itil T.M., Holden J.M.C., Hsu W. Qualitative and quantitative EEG changes of intramuscular thiothixene and trifluoperazine in chronic schizophrenia. Dis. Nerv. Syst. 33:1972;40-45.
5. Bardgett M.E., Jackson J.L., Taylor G.T., Csernansky J.G. Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: an animal model of schizophrenia. Behav. Brain Res. 70:1995;153-164.
6. Bell D.S. Comparison of amphetamine psychosis and schizophrenia. Br. J. Psychiatry. 3:1965;701-707.
7. Bland B.H., Trepel C., Oddie S.D., Kirk I.J. Intraseptal microinfusion of muscimol: effects on hippocampal formation theta field activity and phasic theta-on cell discharges. Exp. Neurol. 138:1996;286-297.
8. Bleular EP. Dementia praecox or the group of schizophrenias (1908). Translated by Zinkin J. New York: International University Press, 1950.
9. Burns L.H., Everitt B.J., Kelley A.E., Robbins T.W. Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement. Psychopharmacology. 115:1994;516-528.
10. Cohen B.D., Rosenbaum G., Luby E.D., Gottlieb J.S. Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Arch. Gen. Psychiatry. 6:1962;395-401.
11. Conrad A.J., Abebe T., Austin R., Forsythe S., Scheibel A.B. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch. Gen. Psychiatry. 48:1991;413-417.
12. Ellison G. Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula. Brain Res. Rev. 19:1994;223-239.
13. Flor-Henry P. Lateralized temporal-limbic dysfunction and psychopathology. Ann. N. Y. Acad. Sci. 280:1976;777-797.
14. Fauman M.A., Fauman B.J. The psychiatric aspects of chronic phencyclidine use: a study of chronic PCP users. Natl. Inst. Drug Abuse Res. Monogr. Ser. 21:1978;183-200.
15. Glick S.D., Meibach R.C., Cox R.D., Maayani S. Phencyclidine-induced rotation and hippocampal modulation of nigrostriatal asymmetry. Brain Res. 196:1980;99-107.
16. Garver D.L., Schlemmer R.F., Maas J.W., Davis J.M. A schizophreniform behavioral psychosis mediated by dopamine. Am. J. Psychiatry. 132:1975;33-38.
17. Groenewegen H.J., Vermeulen-Van Der Zee E., Te Kortschot A. Organization of the projections from the subiculum to the ventral striatum in the rat: a study using anterograde transport of phaseolus vulgaris leucoagglutinin. Neuroscience. 23:1987;103-120.
18. Hiramatsu M., Cho A.K., Nabeshima T. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonist, MK-801 and phencyclidine. Eur. J. Pharmacol. 166:1989;359-366.
19. Itil T.M. The use of electroencephalography in the practice of psychiatry. Psychosomatics. 23:1982;799-813.
20. Itil T.M., Saletu B., Davis S. EEG findings in chronic schizophrenics based on digital computer period analysis and analog power spectra. Biol. Psychiatry. 5:1972;1-13.
21. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148:1991;1301-1308.
22. Jefferys J.G.R., Traub R.D., Whittington M.A. Neuronal networks for induced ’40 Hz’ rhythms. Trends Neurosci. 19:1996;202-208.
23. Jeste D.V., Lohr J.B. Hippocampal pathologic findings in schizophrenia, a morphometric study. Arch. Gen. Psychiatry. 46:1989;1019-1024.
24. Kelley A.E., Domesick V.B. The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: an anterograde- and retrograde-horseradish peroxidase study. Neuroscience. 7:1982;2321-2335.
25. Kerwin R., Patel S., Meldrum B. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience. 39:1990;25-32.
26. Kim J.-H., Vezina P. Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. J. Pharmacol. Exp. Ther. 284:1998;317-322.
27. Leung L.S. Spectral analysis of hippocampal EEG in the freely moving rat: effects of centrally active drugs and relations to evoked potentials. Electroencephalogr. Clin. Neurophysiol. 60:1985;65-77.
28. Leung L.S. Hippocampal electrical activity following local tetanization. I. Afterdischarges. Brain Res. 419:1987;173-187.
29. Leung L.S. Fast (beta) rhythms in the hippocampus: a review. Hippocampus. 2:1992;93-98.
30. Leung L.S. Generation of theta and gamma rhythms in the hippocampus. Neurosci. Behav. Rev. 22:1998;275-290.
31. Leung L.S., Lopes da Silva F.H., Wadman W.J. Spectral characteristics of the hippocampal EEG in the freely moving rat. Electroencephalogr. Clin. Neurophysiol. 54:1982;203-219.
32. Luisada P.V. The phencyclidine psychosis: phenomenology and treatment. Natl. Inst. Drug Abuse Res. Monogr. Ser. 21:1978;241-253.
33. Ma J., Brudzynski S.M., Leung L.S. Involvement of the nucleus accumbens-ventral pallidal pathway in postictal behavior induced by a hippocampal afterdischarge in rats. Brain Res. 739:1996;26-35.
34. Ma J., Brudzynski S.M., Leung L.S. A role of subicular and hippocampal afterdischarges in initiation of locomotor activity in rats. Brain Res. 793:1998;112-118.
35. Ma J., Leung L.S. Medial septum mediates the increase in postictal behaviors and hippocampal gamma waves after an electrically induced seizure. Brain Res. 833:1999;51-57.
36. McCullough L.D., Salamone J.D. Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens. Brain Res. 577:1992;1-9.
37. Meibach R.C., Glick S.D., Cox R., Maayani S. Localisation of phencyclidine-induced changes in brain energy metabolism. Nature. 282:1979;625-626.
38. Mittleman G., LeDuc P.A., Whishaw I.Q. The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia. Behav. Brain Res. 55:1993;253-267.
39. Mogenson G.J., Brudzynski S.M., Wu M., Yang C.R., Yim C.Y. From motivation to action: A review of dopaminergic regulation of limbic-nucleus accumbens-ventral pallidum-pedunculopontine nucleus circuitries involved in limbic-motor integration. Kalivas P.W., Barnes C.D. Limbic Motor Circuits and Neuropsychiatry. 1993;193-225 CRC Press, Boca Raton, FL.
40. Nishikawa T., Umino A., Tanii R., Hashimoto A., Hata N., Takashima M., Takahashi K., Toru M. Dysfunction of excitatory amino acidergic systems and schizophrenic disorders. Nakazawa T. Biological Basis of Schizophrenic Disorders, Taniguchi Symposia on Brain Sciences No. 14. 1991;65-76 Japan Scientific Societies Press, Tokyo.
41. Oddie S.D., Stefanek W., Kirk I.J., Bland B.H. Intraseptal procaine abolishes hypothalamic stimulation-induced wheel-running and hippocampal theta field activity in rats. J. Neurosci. 16:1996;1948-1956.
42. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, Sydney.
43. Petsche H., Stumpf C., Gogolak G. The significance of the rabbit’s septum as a relay station between the midbrain and the hippocampus. I. The control of hippocampus arousal activity by the septum cells. Electroencephalogr. Clin. Neurophysiol. 14:1962;202-211.
44. Pijnenburg A.J.J., Honig W.M.M., Van Rossum J.M. Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat. Psychopharmacologia. 41:1975;87-95.
45. Raja S.N., Guyenet P.G. Action of phencyclidine on synaptic transmission in the hippocampus. Brain Res. 236:1982;289-304.
46. Robinson T.E. The neurobiology of amphetamine psychosis: evidence from studies with an animal model. Nakazawa T. Biological Basis of Schizophrenic Disorders, Taniguchi Symposia on Brain Sciences No. 14. 1991;185-201 Japan Scientific Societies Press, Tokyo.
47. Rose G., Pang K., Palmer M., Freedman R. Differential effects of phencyclidine upon hippocampal complex-spike and theta neurons. Neurosci. Lett. 45:1984;141-146.
48. Saletu B., Saletu M., Itil T.M., Marasa J. The relationship between somatosensory evoked potential and quantitatively analysed EEG during psychotropic drug treatment. Psychophysiology. 9:1972;276.
49. Smith D.E., Wesson D.R., Buxton M.E., Seymour R., Kramer H.M. The diagnosis and treatment of the PCP abuse syndrome. Natl. Inst. Drug Abuse Res. Monogr. Ser. 21:1978;229-240.
50. Snyder S.H. Amphetamine psychosis: a ’model’ schizophrenia mediated by catecholamines. Am. J. Psychiatry. 130:1973;61-67.
51. Snyder S.H. Phencyclidine. Nature. 285:1980;355-356.
52. Snyder S.H. Psychotogenic drugs as models of schizophrenia. Neuropsychopharmacology. 1:1988;197-199.
53. Steinpreis R.E. The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis. Behav. Brain Res. 74:1996;45-55.
54. Steinpreis R.E., Salamone J.D. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study. Brain Res. 612:1993;263-270.
55. Stewart M., Fox S.E. Do septal neurons pace the hippocampal theta rhythm? Trends Neurosci. 13:1990;163-168.
56. Stringer J.L., Greenfield L.J., Hackett J., Guyenet P.G. Blockede of long-term potentiation by phencyclidine and σ opiates in the hippocampus in vivo and in vitro. Brain Res. 280:1983;127-138.
57. Stringer J.L., Guyenet P.G. Effect phencyclidines on hippocampal pyramidal cells. Brain Res. 252:1982;343-352.
58. Suddath R.L., Casanova M.F., Goldberg T.E., Daniel D.G., Kelsoe J.R. Jr, Weinberger D.R. Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. Am. J. Psychiatry. 146:1989;464-472.
59. Vanderwolf C.H. Hippocampal electrical activity and voluntary movement in the rat. Electroencephalogr. Clin. Neurophysiol. 26:1969;407-418.
60. Vanderwolf C.H. Neocortical and hippocampal activation in relation to behavior: effect of atropine, eserine, phenothiazines and amphetamine. J. Comp. Physiol. Psychol. 88:1975;300-323.
61. Vanderwolf C.H., Kramis R., Gillespie L.A., Bland B.H. Hippocampal rhythmic slow activity and neocortical low-voltage fast activity: relations to behavior. Isaacson R.L., Pribram K.H. The Hippocampus. 2:1975;101-128 Plenum, New York.
62. Vanderwolf C.H., Leung L.S. Hippocampal rhythmical slow activity: a brief history and the effects of entorhinal lesions and phencyclidine. Siefert W. Neurobiology of the Hippocampus. 1983;225-302 Academic Press, New York.
63. Vanderwolf C.H., McLauchlin M., Dringenberg H.C., Baker G.B. Brain structures involved in the behavioral stimulant effect of central serotonin release. Brain Res. 772:1997;121-134.
64. Vincent J.P., Kartalovski B., Geneste P., Kamenka J.M., Lazdunski M. Interaction of phencyclidine (’angel dust’) with a specific receptor in rat brain membranes. Proc. Natl. Acad. Sci. USA. 76:1979;4678-4682.
65. Walaas I., Fonnum F. Biochemical evidence for glutamate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat brain. Neuroscience. 5:1980;1691-1698.
66. Whittington M.A., Traub R.D., Jefferys J.G.R. Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation. Nature. 373:1995;613-615.
67. Wu J., Buchsbaum M.S., Johnson C., Bunney W.E. Positron emission tomography study of phencyclidine users as a possible drug model of schizophrenia. Nakazawa T. Biological Basis of Schizophrenic Disorders, Taniguchi Symposia on Brain Sciences No. 14. 1991;217-220 Japan Scientific Societies Press, Tokyo.